亚太微创青光眼手术 (MIGS) 设备市场，按产品（MIGS 支架、MIGS 分流器等）、目标（小梁网脉络膜上腔结膜下滤过和减少房水产生）、手术类型（合并白内障的青光眼和独立青光眼）、最终用户（医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 等）、分销渠道（直接招标和零售销售）- 行业趋势和预测到 2029 年。
亚太地区微创青光眼手术 (MIGS) 设备市场分析及规模
微创青光眼手术用于治疗开角型青光眼。最初，为了治疗开角型青光眼，医生会使用药物减少房水产生或增加房水流出。对于轻度至中度的开角型青光眼，传统上会进行药物和激光治疗。随着微创青光眼手术 (MIGS) 的出现，为不适合进行传统手术的患者创造了新的选择。老年人口的增加和政府预防失明的举措的增加预计将推动市场的发展。从青光眼药物到微创青光眼手术的快速转变可能会为 MIGS 设备制造商创造机会。然而，较差的报销设施可能会成为市场发展的障碍。
微创手术需求的上升是由于眼部疾病发病率的上升、微创手术需求的上升以及手术创伤的减少，从而推动了预测期内市场的需求。然而，高昂的安装成本和熟练专业人员的短缺可能会阻碍预测期内微创手术市场的增长。
Data Bridge Market Research 分析，微创青光眼手术 (MIGS) 设备市场预计到 2029 年将达到 7.8704 亿美元的价值，预测期内的复合年增长率为 30.6%。由于微创青光眼手术 (MIGS) 设备商业化的技术途径发展迅速，“MIGS 支架”占据了微创青光眼手术 (MIGS) 设备市场中最大的技术细分市场。微创青光眼手术 (MIGS) 设备市场报告还深入介绍了技术进步。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品（MIGS 分流器、MIGS 支架等）、目标（小梁网、脉络膜上腔、结膜下滤过和减少房水产生）、手术（青光眼合并白内障、独立青光眼）、最终用户（医院、眼科诊所、门诊手术中心 (ASCS) 等）、分销渠道（直接招标和零售） |
|
覆盖国家 |
亚太地区的中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾、亚太地区其他地区 |
|
涵盖的市场参与者 |
AbbVie、BVI、Ellex、Glaukos Corporation、强生、爱尔康、Microsurgical technology、New World Medical、参天制药、Nova Eye Medical Limited、Belkin Vision 和 Sight Scientific 等。 |
市场定义
MIGS 代表微创青光眼手术，有助于治疗青光眼。这是治疗轻度至中度青光眼的突破性技术。它是之前药物治疗的替代品，还可以预防传统手术的并发症。这些手术用于降低眼内压，避免损伤视神经。与传统手术相比，这些手术更安全，恢复时间非常快。植入的各种 MIGS 设备包括分流器和支架，用于降低眼压。
微创青光眼手术 (MIGS) 设备市场动态
- 老年人口增加
老年人面临的一个重大健康问题是视力丧失。根据美国家庭医生学会的数据，到 65 岁时，三分之一的人患有视力下降的眼病。老年人口正在迅速增加。因此，老年人对治疗青光眼的先进技术的需求也随之增加。因此，老年人口的增加是市场发展的驱动力。
- 全球青光眼发病率上升
不可逆性全盲的主要原因是青光眼。青光眼是一组眼部疾病，初期症状很少或没有症状，但随后会导致视神经受损，从而导致视力丧失或失明。青光眼的患病率一直在增加。因此，这产生了对 MIGS 设备的需求；因此，青光眼发病率的增加预计将成为市场发展的驱动力。
- 政府采取措施提高公众对预防失明的认识
据世界卫生组织称，至少有 22 亿人患有视力障碍和失明，其中至少有 10 亿人的视力障碍是可以预防的。为了预防这些情况，全球多个国家的政府都采取了举措。这产生了对微创青光眼手术等先进治疗的需求，从而推动了 MIGS 设备市场的发展。因此，预计它将成为市场的驱动力。
- 技术先进产品介绍
青光眼是一种严重的眼部疾病，如果不加以控制，会导致视力丧失。它通常不会导致失明，因为它可以通过现代治疗和许多防止进一步损害的选择来控制。随着科学的发展，青光眼的治疗发生了革命性的变化。随着微创青光眼手术的出现，医学发生了范式转变，因为它可以帮助早期治疗青光眼，避免对小梁切除术等过滤手术的依赖。这也克服了与这些切口手术相关的风险。使用 MIGS 治疗青光眼有各种进展。
市场面临的限制/挑战
- MIGS 设备的严格规定
在美国，任何设备制造商必须完全遵守至少 7 项法规，即企业注册和医疗器械清单、上市前通知 510(k)、上市前批准 (PMA)（仅适用于第三类设备）、临床研究的试验设备豁免 (IDE)、质量体系 (QS) 法规、标签要求和医疗器械报告 (MDR)。这些风险最高的设备需要更严格的上市前申请监管流程来证明安全性和有效性的有效证据。漫长的时间表会导致获取延迟，这可能会限制 MIGS 设备的市场。
- 手术费用高昂
虽然青光眼治疗效果一般，而且比传统的滤过手术更安全，但费用非常高。此外，如果眼压不能立即有效降低，患者可能需要进行后续手术。所有这些因素使得这些手术费用高昂，大多数人无法负担，因此，高昂的手术费用可能会限制市场。
最新动态
- 2022年1月，Glaukos宣布GLK=301在干眼症II期临床试验中招募了首例患者，在成功获得监管机构批准后，该药物将助力公司业务板块增长。
- 2022 年 1 月，爱尔康收购了新型 Hydrus Microstent 的开发商 Ivantis，这是一种微创青光眼手术 (MIGS) 设备。该手术设备旨在降低开角型青光眼患者的眼压。此次收购将增强该公司在眼科手术领域的产品组合。
微创青光眼手术 (MIGS) 设备市场范围
微创青光眼手术 (MIGS) 设备市场根据产品、目标、手术、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- MIGS 支架
- MIGS 分流器
- 其他的
根据产品，微创青光眼手术 (MIGS) 设备市场分为 MIGS 分流器、MIGS 支架和其他设备。
目标
- 小梁网
- 脉络膜上腔
- 结膜下滤过
- 减少水产量
根据目标，微创青光眼手术 (MIGS) 设备市场细分为小梁网、脉络膜上腔、结膜下滤过和减少房水产生。
外科手术
- 青光眼与白内障
- 独立性青光眼
根据手术方式，微创青光眼手术 (MIGS) 设备市场分为与白内障相关的青光眼和独立青光眼。
最终用户
- 医院门诊部（HOPD）
- 眼科诊所
- 门诊手术中心（ASCS）
- 其他的
根据最终用户，微创青光眼手术 (MIGS) 设备市场分为医院门诊部 (HOPD)、眼科诊所、门诊手术中心 (ASCS) 和其他。
分销渠道
- 直接招标
- 零售
根据分销渠道，微创青光眼手术（MIGS）设备市场分为直接招标和零售。
微创青光眼手术 (MIGS) 设备市场区域分析/见解
对微创青光眼手术 (MIGS) 设备市场进行了分析，并按国家、产品、目标、手术、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
微创青光眼手术 (MIGS) 设备市场报告涵盖的国家包括中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾和亚太地区其他地区。
中国在亚太微创青光眼手术 (MIGS) 设备市场中占据主导地位。该地区的需求预计将由市场参与者推动，这些市场参与者专注于扩大其区域产品供应，并通过各种增长战略（如扩张、伙伴关系和协作等）增强其在新兴市场的影响力。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和微创青光眼手术 (MIGS) 设备市场份额分析
微创青光眼手术 (MIGS) 设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域存在、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对微创青光眼手术 (MIGS) 设备市场的关注有关。
微创青光眼手术 (MIGS) 设备市场的一些主要参与者包括 AbbVie、BVI、Ellex、Glaukos Corporation、强生、爱尔康、Microsurgical technology、New World Medical、参天制药、Nova Eye Medical Limited、Belkin Vision 和 Sight Scientific 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INTERNATIONAL STANDARDS
4.2 REGIONAL STANDARDS
4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS
4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS
4.5 FINDINGS AND REGIONAL TRENDS
4.6 COMPETITIVE GROUPING
5 COUNTRY WISE- NO OF PROCEDURES
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 REGULATION
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN THE GERIATRIC POPULATION
7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD
7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS
7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE
7.2 RESTRAINTS
7.2.1 INADEQUATE REIMBURSEMENT SCENARIO
7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
7.2.3 HIGH COST OF SURGICAL PROCEDURES
7.3 OPPORTUNITIES
7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY
8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 MIGS STENTS
8.3 MIGS SHUNTS
8.4 OTHERS
9 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
9.1 OVERVIEW
9.2 TRABECULAR MESHWORK
9.3 SUPRACHOROIDAL SPACE
9.4 SUBCONJUNCTIVAL FILTRATION
9.5 REDUCING AQUEOUS PRODUCTION
10 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
10.1 OVERVIEW
10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
10.3 STAND-ALONE GLAUCOMA
11 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.3 OPHTHALMOLOGY CLINICS
11.4 AMBULATORY SURGERY CENTERS (ASCS)
11.5 OTHERS
12 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
13 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 SINGAPORE
13.1.7 THAILAND
13.1.8 MALAYSIA
13.1.9 INDONESIA
13.1.10 PHILIPPINES
13.1.11 REST OF ASIA-PACIFIC
14 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 GLAUKOS CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.4.1 RECENT DEVELOPMENT
16.2 ALCON INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.4.1 RECENT DEVELOPMENTS
16.3 ABBVIE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.4.1 RECENT DEVELOPMENT
16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.4.1 RECENT DEVELOPMENT
16.5 SANTEN PHARMACEUTICAL CO., LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.4.1 RECENT DEVELOPMENTS
16.6 BELKIN VISION, ISRAEL
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BVI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.2.1 RECENT DEVELOPMENTS
16.8 ELLEX INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.2.1 RECENT DEVELOPMENTS
16.9 IOPTIMA
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC)
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.2.1 RECENT DEVELOPMENT
16.11 NEW WORLD MEDICAL, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.2.1 RECENT DEVELOPMENTS
16.12 NOVA EYE MEDICAL LIMITED
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.3.1 RECENT DEVELOPMENTS
16.13 SIGHT SCIENCES.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.3.1 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040
TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT
TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS
TABLE 4 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 25 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 26 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 27 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 28 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 29 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 30 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 31 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 32 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 33 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 35 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 36 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 37 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 38 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 39 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 42 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 43 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 44 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 45 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 46 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 47 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 48 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 50 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 51 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 52 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 53 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 55 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 56 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 57 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 58 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 59 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 60 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 61 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 62 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 63 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 66 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 67 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 68 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 69 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 70 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 71 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 72 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 73 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 74 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 75 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 76 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 77 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 78 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 79 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 80 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021
FIGURE 15 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 16 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2021
FIGURE 19 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022-2029 (USD MILLION)
FIGURE 20 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2021
FIGURE 23 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION)
FIGURE 24 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2021
FIGURE 27 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 31 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 32 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 33 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 35 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 36 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 37 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 38 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 39 ASIA PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
